Optimizing collagenase Clostridium histolyticum therapy for Peyronie's disease using a novel approach with percutaneous needle tunnelling.

Esaú Fernández-Pascual Francisco Javier González-García Javier AnguloEugenio CerezoLuis M QuintanaJorge TuroClaudio Martínez-BallesterosJoaquín CarballidoJuan Ignacio Martínez-Salamanca

Published in: BJU international (2019)

Treatment of PD with CCH using our modified protocol in combination with PNT is safe and more effective than the modified protocol alone, with the potential for improved cost-effectiveness.

Keyphrases

ultrasound guided
randomized controlled trial
minimally invasive
radiofrequency ablation
risk assessment
human health